Matinas Biopharma Holdings Inc. (MTNB) Gained 10.08% or 0.04 To Price $0.45 On Monday


Matinas Biopharma Holdings Inc. (MTNB) gained 10.08% or 0.04 to $0.45. It is approximately 326494 shares traded, which is 137.65% compare to the average total volume 237186. The market cap of MTNB is $42.56 million. The year to date change is -56.95%. The 52 week price range is from $0.32 to $1.6. Price of MTNB have changed -1.49% during last week. It have changed 4.82% over last month, -9.16% over last 3 months, -56.97% over last 6 months and -67.81% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 0.40. It is -11.11% below current price. The 200-day Moving Averages for MTNB is 0.75. It is 66.67% above current price. The 52-week High is 1.6. It is 255.56% from the current price. The 52-week Low is 0.32. It is -28.89% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 7.69 on 2018-08-31. Short % to float is 1.85%. There are some statistics of MTNB. It is has market cap $42.56 million. The share outstanding is 94.58 million. The average volume is 237186. The percent of top 15 Institution holding is 6.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -315.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -88.51%.


Tags:

Share this post